X
Dear User,
On May 25, 2018, Regulation (EU) 2016/679 of the European Parliament and of the Council of April 27, 2016 (General Data Protection Regulation) came into force. We encourage you to familiarise yourself with information about the processing of personal data on the PolskieRadio.pl website.
1.The Data Administrator is Polish Radio S.A., based at 77/85 Niepodległości Ave., 00-977, Warsaw.
2.On issues regarding your data, please contact the Data Protection Officer, e-mail: iod@polskieradio.pl, tel. 22 645 34 03.
3.Personal data may be processed for marketing purposes based on consent.
4.Personal data may be shared solely for the purpose of proper implementation of services defined in the privacy policy.
5.Personal data will not be transferred outside the European Economic Area or to an international organisation.
6.Personal data will be stored for 5 years after an account is deactivated, in accordance with the law.
7.You have the right to access your personal data, correct it, to have it moved or deleted, or to limit its processing.
8.You have the right to object to further processing, and in the case of voicing consent to the processing of personal data, you have the right to withdraw your consent. The exercise of the right to withdraw consent does not affect any processing that has already taken place.
9.You have the right to lodge a complaint with the supervisory authority.
10.Polish Radio S.A. declares that no automated decisions are made when personal data is processed, and that profiling is not used.
For more information on this subject, please read our personal data and privacy policy.
I UNDERSTAND
English Section

Britain approves Pfizer-BioNTech COVID-19 vaccine for use

02.12.2020 10:00
Britain on Wednesday became the first country in the world to approve the Pfizer-BioNTech COVID-19 vaccine for general use, with plans to roll it out from early next week, news agencies reported.
Photo:
Photo:PAP/EPA/BIONTECH SE/HANDOUT

The UK government said it on Wednesday “accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer-BioNTech’s COVID-19 vaccine for use.”

It added in a statement that the vaccine “will be made available across the UK from next week.”

Health Secretary Matt Hancock said the vaccine would first go to the elderly, those in care homes and their carers, and to those who are clinically vulnerable, the Reuters news agency reported.

Poland's Deputy Health Minister Waldemar Kraska said on Tuesday that his country would start an anti-coronavirus vaccination programme as soon as a vaccine appears.

“We want to vaccinate as many Poles as possible, so when there is a vaccine, we will immediately begin vaccination," Kraska told state broadcaster TVP Info.

He added that the health minister would on Wednesday give details of how Poland is preparing for such a programme.

Poland’s prime minister said last month that millions of vaccines against the coronavirus were likely to reach his country next spring as part of a European deal with drug makers.

Prime Minister Mateusz Morawiecki said on November 13 that his government has set up a working group with experts from US pharmaceutical firm Pfizer amid efforts to make a COVID-19 vaccine available to Poles as quickly as possible.

In mid-November, Morawiecki also talked with executives from global pharmaceutical company AstraZeneca as part of efforts to secure a COVID-19 vaccine for Poland, state news agency PAP reported.

The European Union, of which Poland is part, has already struck deals to secure vaccines from Pfizer-BioNTechAstraZenecaModernaCureVacSanofi-GSK, and Johnson & Johnson, taking its potential stock of COVID-19 shots to nearly 2 billion, news agencies have reported.

The European Medicines Agency (EMA) could produce a scientific opinion on COVID-19 vaccines seeking regulatory approval by the end of the year in a best case scenario, the regulator's new chief was quoted as saying last week.

(gs/pk)

Source: Reuters, IAR, PAP, gov.uk